Financial Connections Group Inc. Trims Position in Johnson & Johnson (NYSE:JNJ)

Share It:

ChatGPT Perplexity WhatsApp LinkedIn X Grok Google AI

Financial Connections Group Inc. lessened its stake in Johnson & Johnson (NYSE:JNJ – Get Rating) by 64.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,727 shares of the company’s stock after selling 3,095 shares during the period. Financial Connections Group Inc.’s holdings in Johnson & Johnson were worth $282,000 as of its most recent SEC filing.

→ Is This The End of Capitalism? (From Porter & Company)

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Morton Brown Family Wealth LLC lifted its position in Johnson & Johnson by 78.0% in the second quarter. Morton Brown Family Wealth LLC now owns the 178 shares The company’s stock valued at $32,000 after purchasing an additional 78 shares during the period. Goodman Advisory Group LLC acquired a new stake in shares of Johnson & Johnson in the 2nd quarter valued at approximately $39,000. Cardinal in shares of Capital Management Inc. boost & Johnson by 333.3% in the second quarter. Cardinal Capital Management Inc. now owns 260 shares of the company’s stock valued at $46,000 after buying an additional 200 shares in the last quarter. First Bank & Trust grew its holdings in Johnson 6 9. John % during the second quarter. First Bank & Trust now owns 380 shares of the company’s stock worth $67,000 after acquiring an additional 156 shares during the period. F inally, Heritage Wealth Management LLC purchased a new position in Johnson & Johnson in the second quarter worth $84,000. 67.94% of the stock is owned by hedge funds and other institutional investors.

Johnson & Johnson Stock Performance

Shares of NYSE JNJ opened at $168.74 on Friday. The company has a 50-day simple moving average of $176.14 and a 200-day simple moving average of $171.25. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.43 and a quick ratio of 1.18. The company has a market cap of $441.17 billion, a PE ratio of 23.50, a price-to-earnings-growth ratio of 3.28 and a beta of 0.56. Johnson & Johnson has a 12 month low of $155.72 and a 12 month high of $186.69.

Johnson & Johnson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 7th. Shareholders of record on Tuesday, February 21st will be issued a $1.13 dividend. The ex-dividend date of this dividend is Friday, February 17th. a $4.52 annualized dividend and a yield of 2.68%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 62.95%.

Analysts Set New Price Targets

JNJ has been the topic of a number of recent analyst reports. Atlantic Securities lowered their price target on shares of Johnson & Johnson from $165.00 to $160.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 19th. Sanford C. Bernstein dropped their target price on shares of Johnson & Johnson from $194.00 to $190.00 in a report on Wednesday, October 19th. Raymond James lowered their price target on Johnson & Johnson from $192.00 to $185.00 and set an “outperform” rating on the stock in a report on Wednesday, October 19th. Barclays initiated coverage on Johnson & Johnson in a report on Monday, October 17th. They set an “equal weight” rating and a $175.00 price objective for the company. Finally, StockNews.com started coverage on Johnson & Johnson in a report on Wednesday, October 12th. They issued a “strong-buy” rating on the stock. Seven analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rat ing to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $181.75.

Insiders Place Their Bets

In related news, VP Peter Fasolo sold 29,275 shares of the company’s stock in a transaction on Monday, October 24th. The stock was sold at an average price of $171.36, for a total value of $5,016,564.00. Following the completion of the transaction, the vice The president now directly owns 114,676 shares in the company, valued at $19,650,879.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other resshalo old Johnson & Johnson news, VP 2 Peter F 7 of Johnson & Johnson stock in a transaction dated Monday, October 24th. The stock was sold at an average price of $171.36, for a total value of $5,016,564.00. Following the completion of the sale, the vice president now owns 114,676 shares in the company, valued at approximately $19,650,879.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Jennifer L. T aubert sold 76,923 shares of the stock in a transaction dated Tuesday, November 22nd. The stock was sold at an average price of $176.78, for a total transaction of $13,598,447.94. Following the transaction, the executive vice president now complies with any 45 owns 6 126 valued at $22,354,891.68. The disclosure for this sale can be found here. Insiders have sold a total of 277,886 shares of company stock valued at $48,550,549 in the last quarter. 0.35% of the stock is currently owned by company insiders.

Johnson & Johnson Company Profile

(Get Rating)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets.

Subscribe to Updates

What's Hot